CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study of Veliparib (ABT-888) in Combination With Capecitabine and Temozolomide in Advanced Well-Differentiated Neuroendocrine Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02831179
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:48.226022+00:00
Published At: 2017-09-28T00:00:00+00:00
Record Updated At: 2017-09-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Functional Pancreatic Neuroendocrine Tumor", "Malignant Somatostatinoma", "Merkel Cell Carcinoma", "Metastatic Adrenal Gland Pheochromocytoma", "Metastatic Carcinoid Tumor", "Multiple Endocrine Neoplasia Type 1", "Multiple Endocrine Neoplasia Type 2A", "Multiple Endocrine Neoplasia Type 2B", "Neuroendocrine Neoplasm", "Non-Functional Pancreatic Neuroendocrine Tumor", "Pancreatic Glucagonoma", "Pancreatic Insulinoma", "Recurrent Adrenal Cortex Carcinoma", "Recurrent Adrenal Gland Pheochromocytoma", "Recurrent Merkel Cell Carcinoma", "Somatostatin-Producing Neuroendocrine Tumor", "Stage III Adrenal Cortex Carcinoma", "Stage III Thyroid Gland Medullary Carcinoma", "Stage IIIA Merkel Cell Carcinoma", "Stage IIIB Merkel Cell Carcinoma", "Stage IV Adrenal Cortex Carcinoma", "Stage IV Merkel Cell Carcinoma", "Stage IVA Thyroid Gland Medullary Carcinoma", "Stage IVB Thyroid Gland Medullary Carcinoma", "Stage IVC Thyroid Gland Medullary Carcinoma", "Thymic Carcinoid Tumor", "VIP-Producing Neuroendocrine Tumor", "Well Differentiated Adrenal Cortex Carcinoma", "Zollinger Ellison Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-09-28"
protocolSection.identificationModule.nctId: "NCT02831179"
protocolSection.identificationModule.officialTitle: "A Phase 1 Study of Veliparib (ABT-888) in Combination With Capecitabine and Temozolomide in Advanced Well-Differentiated Neuroendocrine Tumors"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Study condition terms

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.